JURA Bio, Inc.
PrivateLast Round
Seed
Sep 21, 2023
Total Funding Raised
$16.14M
Company Overview
JURA Bio, Inc. is a biotechnology company that develops immune-based therapeutics for autoimmune diseases and oncology by integrating generative machine learning and synthetic biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
JURA Bio, Inc. Comparables
Compare JURA Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla Bio | 86% | |
| BigHat Biosciences | 83% | |
| Manifold Bio | 83% | |
JURA Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 21, 2023 | ||||
| Grant | Dec 22, 2022 |
JURA Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LabCentral Ignite | Grant |
| Massachusetts Life Sciences Center | Grant |
| Mintz | Grant |
| Fontus Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2022
$44K grant received from Sanofi and Takeda.
JURA Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about JURA Bio, Inc.'s valuation, stock price, and market status.